Centessa Pharmaceuticals (LTS:0ACX) Accounts Payable & Accrued Expense : $20.80 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Centessa Pharmaceuticals Accounts Payable & Accrued Expense?

Centessa Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2024 ($19.26 Mil) to Dec. 2024 ($47.82 Mil) but then declined from Dec. 2024 ($47.82 Mil) to Mar. 2025 ($20.80 Mil).

Centessa Pharmaceuticals's annual accounts payable & accrued expense increased from Dec. 2022 ($30.38 Mil) to Dec. 2023 ($31.81 Mil) and increased from Dec. 2023 ($31.81 Mil) to Dec. 2024 ($47.82 Mil).

Centessa Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Centessa Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals Accounts Payable & Accrued Expense Chart

Centessa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2.07

19.67

30.38

31.81

47.82

Centessa Pharmaceuticals Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial													23.52	21.48	19.26	47.82	20.80

Centessa Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Centessa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (LTS:0ACX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CNTA:USA

Address

1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT

Website

https://www.centessa.com

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Centessa Pharmaceuticals Headlines

No Headlines